Yuanqing Guo

#786 Yuyuan Road
Changning, 200051, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Development of an LC-MS/MS method to quantitatively analyze escitalopram and its metabolites with application in liver and placenta microsome metabolism.

Development of an LC-MS/MS method to quantitatively analyze escitalopram and its metabolites with application in liver and placenta microsome metabolism.

Journal: Frontiers in pharmacology

Published: September 28, 2025

Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine.

Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine.

Journal: Biochemical pharmacology

Published: August 26, 2025

Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport.

Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport.

Journal: Toxicology and applied pharmacology

Published: July 01, 2024

Construction of cytochrome P450 3A and P-glycoprotein knockout rats with application in rivaroxaban-verapamil interactions.

Construction of cytochrome P450 3A and P-glycoprotein knockout rats with application in rivaroxaban-verapamil interactions.

Journal: Biochemical pharmacology

Published: February 27, 2024

Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats.

Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats.

Journal: Biochemical pharmacology

Published: January 15, 2024

Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.

Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.

Journal: Acta pharmaceutica Sinica. B

Published: September 21, 2023

Establishment of LC-MS/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes.

Establishment of LC-MS/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes.

Journal: Journal of pharmaceutical and biomedical analysis

Published: March 17, 2023

Design and Construction of Carboxylesterase 2c Gene Knockout Rats by CRISPR/Cas9.

Design and Construction of Carboxylesterase 2c Gene Knockout Rats by CRISPR/Cas9.

Journal: Current drug metabolism

Published: September 11, 2022

Prenatal screening and diagnosis for a fetus with mosaic sex chromosome abnormality

Prenatal screening and diagnosis for a fetus with mosaic sex chromosome abnormality

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: July 10, 2022

Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats.

Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats.

Journal: Toxicology letters

Published: December 08, 2021

P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats.

P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats.

Journal: Toxicology and applied pharmacology

Published: May 11, 2021

Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9.

Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: February 02, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026